Phase I/II study of nivolumab with or without ipilimumab for treatment of recurrent small cell lung cancer (SCLC): CA209-032

标题
Phase I/II study of nivolumab with or without ipilimumab for treatment of recurrent small cell lung cancer (SCLC): CA209-032
作者
关键词
-
出版物
Journal for ImmunoTherapy of Cancer
Volume 3, Issue Suppl 2, Pages P376
出版商
Springer Nature
发表日期
2015-11-05
DOI
10.1186/2051-1426-3-s2-p376

向作者/读者发起求助以获取更多资源

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now